Edwards Lifesciences Corporation Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount
Edwards Lifesciences Corporation (EW) reported Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount of $1.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Annual Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount · last filed 2026-02-25
- Edwards Lifesciences Corporation equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2024-03-31 was $2.40M.
- Edwards Lifesciences Corporation equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2018-09-30 was $100.00K.
- Edwards Lifesciences Corporation equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2018-06-30 was $1.80M.
- Edwards Lifesciences Corporation equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2025 was $1.80M, a 41.94% decline from fiscal 2024.
- Edwards Lifesciences Corporation equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2024 was $3.10M.
- Edwards Lifesciences Corporation equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Edwards Lifesciences Corporation equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2022 was $500.00K.
| Period end | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.80M 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $3.10M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $2.40M 10-Q · filed 2024-11-06 | |||
| 2024-06-30 | $2.40M 10-Q · filed 2024-07-31 | |||
| 2024-03-31 | $2.40M 10-Q · filed 2024-04-29 | |||
| 2023-12-31 | $0.00 10-K · filed 2024-02-12 | |||
| 2022-12-31 | $500.00K 10-K · filed 2024-02-12 | |||
| 2018-09-30 | $100.00K 10-Q · filed 2018-10-26 | $1.90M 10-Q · filed 2018-10-26 | ||
| 2018-06-30 | $1.80M 10-Q · filed 2018-07-27 | $1.80M 10-Q · filed 2018-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |